Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02994927 |
|---|---|
| Brief Title: | A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE) |
| First Submitted : | December 11, 2016 |
| First Submitted that Met QC Criteria : | December 13, 2016 |
| First Posted : | December 16, 2016 (Estimate) |
| Results First Submitted : | May 19, 2022 |
| Results First Posted with QC Comments : | June 21, 2022 |
| Results First Submitted that Met QC Criteria : | August 12, 2022 |
| Results First Posted : | September 9, 2022 |
| Last Update Submitted that Met QC Criteria : | January 25, 2024 |
| Last Update Posted : | January 29, 2024 |